Adipocyte-derived FABP4 promotes metabolism-associated steatotic liver-induced hepatocellular carcinoma by driving ITGB1-mediated β-catenin activation.

J Clin Invest · 2025 · PMC12700556 · PMID 41392988

Europe PMC DOI

hedged sentence

0.0994

closest p · 2.0× alpha

0.0994

boldest claim

The sentences

showed a trendP = 0.0994so close (0.05 < p ≤ 0.1)

Overexpression of FABP4 in these patients in a different cohort showed a trend of HCC recurrence ( GSE214432 , P = 0.0994, data not shown).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.